Plasma p-tau181, p-tau231, and p-tau217, phosphorylated on threonine residues, are excellent indicators of the symptomatic stage of AD, increasing with disease severity and showing strong associations with amyloid and tau pathologies [144]. The gene discussed is MAPT; the disease is Alzheimer disease.